Markets:

Overview

News

Currencies

International

Treasuries

MacroGenics, Inc. - Common Stock (NQ:MGNX)

3.000 -0.120 (-3.85%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 ↗

March 17, 2023

Via Benzinga

Why Shares of MacroGenics Climbed Thursday ↗

March 16, 2023

The cancer-focused biotech delivered a strong earnings report.

Via The Motley Fool

Macrogenics's Return On Capital Employed Insights ↗

March 16, 2023

Via Benzinga

Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday ↗

March 16, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

MacroGenics (MGNX) Q4 2022 Earnings Call Transcript ↗

March 15, 2023

MGNX earnings call for the period ending December 31, 2022.

Via The Motley Fool

The Latest Analyst Ratings for Macrogenics ↗

January 19, 2023

Via Benzinga

Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 16, 2023

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...

Via Benzinga

Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗

March 13, 2023

U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

7 Analysts Have This to Say About Macrogenics ↗

November 23, 2022

Via Benzinga

Expert Ratings for Macrogenics ↗

November 23, 2022

Via Benzinga

Earnings Scheduled For March 15, 2023 ↗

March 15, 2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.

Via Benzinga

Why Shares of MacroGenics Jumped Thursday ↗

March 09, 2023

The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 09, 2023

Via Benzinga

General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday ↗

March 09, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 09, 2023

Via Benzinga

MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million

March 08, 2023

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call

March 07, 2023

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

March 02, 2023

From MacroGenics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 17, 2023

Via Benzinga

AutoNation, HubSpot, AMC Networks And Other Big Stocks Moving Higher On Friday ↗

February 17, 2023

U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying ↗

February 17, 2023

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 14, 2023

Via Benzinga

MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients ↗

February 14, 2023

Via Benzinga

MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium

February 13, 2023

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

February 06, 2023

From MacroGenics, Inc.

Via GlobeNewswire

Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday ↗

January 19, 2023

JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market...

Via Benzinga

MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 04, 2023

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors

January 04, 2023

From MacroGenics, Inc.

Via GlobeNewswire

$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying ↗

November 28, 2022

Although US stocks closed mixed on Friday, there were a few notable insider trades.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.